Delivery Order SPE2DR25D1017-SPE2DR26F9DAL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,181.63 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a $27,773.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of January 12, 2026. This competitively awarded, non-set-aside contract was issued on January 9, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $82,443.45 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,685.12 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $35,911.43. This firm fixed-price, competitively awarded delivery order is set to be completed by January 8, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $30,421.57 to AmerisourceBergen Drug Corp for 30-tablet supplies of Arimidex 1 mg tablets. The contract is a firm fixed-price delivery order with no set-aside designation, executed on January 9, 2026, with an ultimate completion date of January 12, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Arimidex (anastrozole) is a hormone therapy medication used in breast cancer...
- The Defense Logistics Agency awarded a delivery order valued at $35.85K to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 12, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, and represents a non-set-aside award issued through competitive procurement. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,953.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 29, 2025, with a completion date of December 30, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DALDelivery Order
The Defense Logistics Agency awarded a $13,575.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on January 12, 2026, with completion targeted for January 13, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This procurement falls within DLA's pharmaceutical supply chain operations supporting military healthcare programs globally. AmerisourceBergen, operating under parent company Cencora, is a major pharmaceutical distributor that supplies a comprehensive range of medications and medical supplies to federal agencies, particularly the Department of Defense and its healthcare systems. Arimidex (anastrozole) is a hormone therapy medication commonly used in cancer treatment, reflecting the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 1/11/26 |